Patents by Inventor Jae-Sun Kim

Jae-Sun Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250137128
    Abstract: Provided are a process gas supply device, which stably controls a temperature of a process gas to supply the process gas, and a substrate processing system including the same. The process gas supply device includes a gas hub to which a process gas is supplied from a gas supply source, a plurality of gas lines branched from the gas hub to transfer the supplied process gas, and an integrated heater part provided to surround the plurality of gas lines and the gas hub so as to heat the gas hub and the plurality of gas lines at the same time.
    Type: Application
    Filed: January 18, 2024
    Publication date: May 1, 2025
    Inventors: In Soo SON, Chang Hun SHIN, Chan Yong PARK, Deog Hwan KIM, Jae Jun JUNG, Si Won RYU, Chang Min PARK, Jae Sun KIM, Ki Hoon KIM, Jong Hoon KIM, Jeong Hyeon KIM, In Seong HWANG
  • Publication number: 20250066920
    Abstract: Provided is a substrate processing apparatus, more particularly, a substrate processing apparatus capable of suppressing an generation of process by-products in a substrate processing process. A substrate processing apparatus includes a chamber part configured to provide an inner space in which a substrate is processed, a gas supply part configured to supply a process gas to the inner space, a substrate support configured to support the substrate, a heating liner provided inside the chamber part to at least partially surround the inner space, and a heating part configured to heat the heating liner.
    Type: Application
    Filed: January 18, 2024
    Publication date: February 27, 2025
    Inventors: In Soo SON, Chang Hun SHIN, Chan Yong PARK, Deog Hwan KIM, Jae Jun JUNG, Si Won RYU, Chang Min PARK, Jae Sun KIM, Ki Hoon KIM, Jong Hoon KIM
  • Publication number: 20250034704
    Abstract: Provided are a substrate processing apparatus and a substrate processing method, which are capable of independently performing processes on a plurality of substrates in a multi-station chamber.
    Type: Application
    Filed: January 18, 2024
    Publication date: January 30, 2025
    Inventors: In Soo SON, Chang Hun SHIN, Chan Yong PARK, Deog Hwan KIM, Jae Jun JUNG, Si Won RYU, Chang Min PARK, Jae Sun KIM, Ki Hoon KIM
  • Publication number: 20250001433
    Abstract: A substrate treating apparatus in which foreign substances are reduced by using a foreign substance collecting unit includes a magnetic structure. The substrate treating apparatus includes a roller configured to be disposed on a rail extending in a first direction and attached to a side surface of a carrier unit to move along the rail, and a foreign substance collecting unit installed on the side surface of the carrier unit, moving together with the roller, and configured to be spaced apart from the rail when the roller is disposed on the rail, wherein the foreign substance collecting unit includes a magnetic structure for adsorbing foreign magnetic substances using a magnetic force, and a case surrounding the magnetic structure.
    Type: Application
    Filed: January 31, 2024
    Publication date: January 2, 2025
    Applicants: Samsung Electronics Co., Ltd., KCTECH CO.,LTD.
    Inventors: Suk Min CHOI, Yun Seok CHOI, Byoung Chaul SON, Dong Cheol SIM, Jae Sun KIM, Jae Hyun SUNG, Eun Seok LEE
  • Publication number: 20240261283
    Abstract: The present disclosure relates to medical use of a compound of chemical formula 1 for treatment or prevention of pulmonary fibrosis. The present disclosure also relates to combination therapy with the compound of chemical formula 1 and nintedanib.
    Type: Application
    Filed: May 31, 2022
    Publication date: August 8, 2024
    Inventors: Hyung-Chul RYU, Jae-Sun KIM, Jee-Woong LIM, Soon-Jin KWON, Seung-Yong LEE
  • Patent number: 12049444
    Abstract: The present invention provides: novel compounds capable of producing monomethyl fumarate after the compounds are administered; pharmaceutical compositions comprising same as active ingredients; and pharmaceutical uses thereof for treating or alleviating various diseases including immune system abnormalities, neurodegeneration, and/or inflammatory diseases.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: July 30, 2024
    Assignee: AGATHONBIO CO., LTD.
    Inventors: Hyung-Chul Ryu, Jae-Sun Kim, Jee-Woong Lim, Yeon-Woo Son
  • Patent number: 12011443
    Abstract: The present invention relates to a medical use of a compound, of Chemical Formula 1, for treating, alleviating or preventing non-alcoholic steatohepatitis (NASH) and/or hepatic fibrosis.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: June 18, 2024
    Assignee: J2H BIOTECH INC.
    Inventors: Jae-Sun Kim, Hyung-Chul Ryu, Jee-Woong Lim, Jung-Gun Joung, Sun-Joo Kim, Yeon-Woo Son, Hyung-Jun Kim, Wenling Song
  • Publication number: 20240150331
    Abstract: The present invention relates to a pidolate salt and malate salt of a compound represented by a formula 1 with an excellent liquid-phase stability, solid-phase stability, water solubility, precipitation stability and hygroscopicity all together as a compound for preventing and treating diseases mediated by an acid pump antagonistic activity, as well as a method for preparing the same.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 9, 2024
    Applicant: HK INNO.N CORPORATION
    Inventors: Eun Sun KIM, Min Kyoung LEE, Sung Ah LEE, Kwang Do CHOI, Jae Sun KIM, Hyung Chul YOO
  • Patent number: 11912690
    Abstract: The present invention relates to a pidolate salt and malate salt of a compound represented by a formula 1 with an excellent liquid-phase stability, solid-phase stability, water solubility, precipitation stability and hygroscopicity all together as a compound for preventing and treating diseases mediated by an acid pump antagonistic activity, as well as a method for preparing the same.
    Type: Grant
    Filed: November 21, 2022
    Date of Patent: February 27, 2024
    Assignee: HK INNO.N CORPORATION
    Inventors: Eun Sun Kim, Min Kyoung Lee, Sung Ah Lee, Kwang Do Choi, Jae Sun Kim, Hyung Chul Yoo
  • Publication number: 20230322723
    Abstract: The present disclosure provides a compound of a specific chemical structure or a pharmaceutically acceptable salt thereof, which has the activity of inhibiting and/or degrading mutant EGFR protein. The present disclosure also provides a composition comprising such a compound or a pharmaceutically acceptable salt thereof. The present disclosure provides a pharmaceutical use of a compound according to the present disclosure, a salt thereof, and a composition comprising same for the treatment or prevention of cancer with EGFR mutation, especially lung cancer. The present disclosure also provides a method for treatment or prevention of EGFR mutation cancer, especially lung cancer, the method comprising administering an effective amount of the compound according to the present invention, a salt thereof, or a composition containing same to a subject in need of treatment.
    Type: Application
    Filed: September 2, 2021
    Publication date: October 12, 2023
    Inventors: Hyung-Chul RYU, Jae-Sun KIM, Jee-Woong LIM, Ju-Young LEE, Kwanghyun CHOI, Rengasamy RAJESH, Duk-Ho CHANG, Hyeok Jun GWON, Hyo Jin KANG
  • Publication number: 20230192670
    Abstract: The present invention relates to a pidolate salt and malate salt of a compound represented by a formula 1 with an excellent liquid-phase stability, solid-phase stability, water solubility, precipitation stability and hygroscopicity all together as a compound for preventing and treating diseases mediated by an acid pump antagonistic activity, as well as a method for preparing the same.
    Type: Application
    Filed: November 21, 2022
    Publication date: June 22, 2023
    Applicant: HK INNO.N CORPORATION
    Inventors: Eun Sun KIM, Min Kyoung LEE, Sung Ah LEE, Kwang Do CHOI, Jae Sun KIM, Hyung Chul YOO
  • Patent number: 11535610
    Abstract: The present invention relates to a pidolate salt and malate salt of a compound represented by a formula 1 with an excellent liquid-phase stability, solid-phase stability, water solubility, precipitation stability and hygroscopicity all together as a compound for preventing and treating diseases mediated by an acid pump antagonistic activity, as well as a method for preparing the same.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: December 27, 2022
    Assignee: HK INNO.N CORPORATION
    Inventors: Eun Sun Kim, Min Kyoung Lee, Sung Ah Lee, Kwang Do Choi, Jae Sun Kim, Hyung Chul Yoo
  • Patent number: 11485716
    Abstract: The present invention relates to a novel compound and a medicinal use of the novel compound. In particular, the present invention relates to a novel compound useful for the treatment and/or prevention of muscular dystrophy, including Duchenne muscular atrophy, and a medicinal use of the novel compound.
    Type: Grant
    Filed: December 24, 2019
    Date of Patent: November 1, 2022
    Assignee: J2H BIOTECH INC.
    Inventors: Hyung-Chul Ryu, Jae-Sun Kim, Jee-Woong Lim, Ju-Young Lee, Wenling Song, Tae-Gon Kim
  • Patent number: 11427547
    Abstract: The present invention provides a novel prodrug of an edaravone compound or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising same as an active ingredient, and a use thereof in treatment or alleviation of neurodegenerative and/or motor neuron disease.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: August 30, 2022
    Assignee: J2H BIOTECH INC.
    Inventors: Jae-Sun Kim, Hyung-Chul Ryu, Jee-Woong Lim, Eun-Bi Kang, Hyuk-Min Kim, Hyunjun Yang, Dukho Chang, Dong-Gyu Kim, Byung Hwan Ryoo, Yong-Ho Oh
  • Publication number: 20220227781
    Abstract: The present invention provides novel pyrimidine derivative compounds inhibiting growth of cancer cells and pharmaceutically acceptable salts thereof. The present invention provides a pharmaceutical composition comprising these compounds or pharmaceutically acceptable salts. The present invention also provides a medical use for treatment of lung cancer, characterized by using these pyrimidine derivative compounds and pharmaceutically acceptable salts thereof as an active ingredient. The present invention also provides a method for treatment of lung cancer comprising administering an effective dose of compounds according to the present invention, salts thereof or a composition comprising them.
    Type: Application
    Filed: June 19, 2020
    Publication date: July 21, 2022
    Inventors: Hyung-Chul RYU, Jae-Sun KIM, Sung-Eun KIM, Sun-Ho LEE, Yong-Hyub LEE
  • Patent number: 11248003
    Abstract: A novel pyrimidine derivative compound and a salt thereof are disclosed. The pyrimidine derivative compound effectively inhibits the growth of C797S mutant EGFR-expressed and MET-amplified cancer cells, which are the main resistance mechanisms of third generation EGFR anticancer agents, and thus may be effectively used in the treatment of lung cancer.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: February 15, 2022
    Assignee: ONCOBIX CO., LTD.
    Inventors: Sung-Eun Kim, Sunho Lee, Rengasamy Rajesh, Dae Ho Kang, Hyung Chui Ryu, Jae-Sun Kim, Sangryul Lee, Kyong Cheol Kim, Jin Kyung Rho, Jae Cheol Lee
  • Publication number: 20220033359
    Abstract: The present invention provides a novel prodrug of an edaravone compound or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising same as an active ingredient, and a use thereof in treatment or alleviation of neurodegenerative and/or motor neuron disease.
    Type: Application
    Filed: September 9, 2019
    Publication date: February 3, 2022
    Inventors: Jae-Sun KIM, Hyung-Chul RYU, Jee-Woong LIM, Eun-Bi KANG, Hyuk-Min KIM, Hyunjun YANG, Dukho CHANG, Dong-Gyu KIM, Byung Hwan RYOO, Yong-Ho OH
  • Publication number: 20220033366
    Abstract: The present invention relates to a novel compound and a medicinal use of the novel compound. In particular, the present invention relates to a novel compound useful for the treatment and/or prevention of muscular dystrophy, including Duchenne muscular atrophy, and a medicinal use of the novel compound.
    Type: Application
    Filed: December 24, 2019
    Publication date: February 3, 2022
    Inventors: Hyung-Chul RYU, Jae-Sun KIM, Jee-Woong LIM, Ju-Young LEE, Wenling SONG, Tae-Gon KIM
  • Publication number: 20210387939
    Abstract: The present invention provides: novel compounds capable of producing monomethyl fumarate after the compounds are administered; pharmaceutical compositions comprising same as active ingredients; and pharmaceutical uses thereof for treating or alleviating various diseases including immune system abnormalities, neurodegeneration, and/or inflammatory diseases.
    Type: Application
    Filed: January 29, 2020
    Publication date: December 16, 2021
    Inventors: Hyung-Chul RYU, Jae-Sun KIM, Jee-Woong LIM, Yeon-Woo SON
  • Publication number: 20210299127
    Abstract: The present invention relates to a medical use of a compound, of Chemical Formula 1, for treating, alleviating or preventing non-alcoholic steatohepatitis (NASH) and/or hepatic fibrosis.
    Type: Application
    Filed: July 19, 2019
    Publication date: September 30, 2021
    Inventors: Jae-Sun KIM, Hyung-Chul RYU, Jee-Woong Lim, Jung-Gun JOUNG, Sun-Joo KIM, Yeon-Woo SON, Hyung-Jun KIM, Wenling SONG